Devices › Lens, guide, intraocular
Device brand name · Lens guide intraocular
AcrySof IQ Singlepiece IOL with ULTRASERT Delivery System: medical device reports filed with FDA
1,878 reports name it, 2017–2026. Manufacturer given most often on reports: Alcon Research - Huntington. Product code KYB.
- 1,878
- device reports naming the brand
- 0% of all MAUDE reports · about 219 a year
- 244
- reports, 12 months to August 2026
- 268 in the 12 months before
- 84.9%
- classified as malfunction
- 81.5% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
1,878 medical device reports received by FDA name the brand "AcrySof IQ Singlepiece IOL with ULTRASERT Delivery System" (lens guide intraocular); the manufacturer given most often on reports is Alcon Research - Huntington; received from December 2017 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
244 reports arrived in the 12 months to August 2026, close to the 268 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (84.9%) and injury (15.1%); across all lens, guide, intraocular reports (product code KYB) death is recorded in 0% and malfunction in 81.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device damaged by another device (11.4%), break (11.2%) and failure to advance (10.3%). The patient problems coded most often are capsular bag tear, eye injury and corneal edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 8,704 reports carrying product code KYB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device damaged by another device | 215 | 11.4% | 7% |
| Breakthe device broke | 210 | 11.2% | 6.6% |
| Failure to advance | 194 | 10.3% | 3.3% |
| Failure to eject | 163 | 8.7% | 3.7% |
| Device difficult to setup or prepare | 145 | 7.7% | 1.6% |
| Defective devicethe device was defective | 139 | 7.4% | 3% |
| Scratched material | 102 | 5.4% | 3% |
| Defective component | 87 | 4.6% | 2% |
| Physical resistance/sticking | 69 | 3.7% | 1.4% |
| Failure to deliverthe device did not deliver the dose or item | 68 | 3.6% | 2.1% |
| Material twisted/bent | 67 | 3.6% | 2.4% |
| Activation, positioning or separation problem | 53 | 2.8% | 0.9% |
| Material split, cut or torn | 47 | 2.5% | 1% |
| Crackthe device cracked | 40 | 2.1% | 5.2% |
| Failure to fold | 37 | 2% | 0.9% |
| Positioning problem | 35 | 1.9% | 0.6% |
| Failure to unfold or unwrap | 34 | 1.8% | 0.4% |
| Unintended ejection | 30 | 1.6% | 0.6% |
| Device contamination with chemical or other material | 28 | 1.5% | 2.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 27 | 1.4% | 1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Capsular bag tear | 68 | 3.6% |
| Eye injury | 35 | 1.9% |
| Corneal edema | 23 | 1.2% |
| Failure of implant | 22 | 1.2% |
| Visual impairmentreduced vision | 20 | 1.1% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 15 | 0.8% |
| Inflammationinflammation | 15 | 0.8% |
| Rupturethe device burst | 15 | 0.8% |
| Blurred vision | 14 | 0.7% |
| Visual disturbances | 11 | 0.6% |
| Endophthalmitisinfection inside the eye | 7 | 0.4% |
| Foreign body in patientpart of a device left in the patient | 7 | 0.4% |
| Tissue damage | 7 | 0.4% |
| Eye paineye pain | 6 | 0.3% |
| No patient involvement | 6 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | AcrySof IQ Singlepiece IOL with ULTRASERT Delivery System | Product code KYB | All MAUDE reports |
|---|---|---|---|
| Reports | 1,878 | 8,704 | 26,136,888 |
| Share of that pool | — | 21.6% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 15.1% | 18.1% | 36.2% |
| Classified as malfunction | 84.9% | 81.5% | 62.3% |
| Filed by the manufacturer | 100% | 99.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code KYB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Monarch Iol Delivery System - Cartridge | 1,449 | 0 | 0% |
| Microstaar Injector | 934 | 0 | 0% |
| Platinum 1 Series | 540 | 0 | 0% |
| AcrySof IQ Aspheric UV Absorbing IOLwith UltraSert Delivery System | 850 | 174 | 0% |
| Microstaar Injector Cartridge | 622 | 0 | 0% |
| Monarch Delivery System | 270 | 0 | 0% |
| Emerald | 294 | 10 | 0% |
| Monarch Iol Delivery System | 214 | 0 | 0% |
| MONARCH IOL Delivery System, Injector, Unspecified | 173 | 50 | 0% |
| Easy Load Inserter | 600 | 0 | 0% |
| Monarch Iol Delivery System-Cartridge | 152 | 0 | 0% |
| Acrysof Iq Singlepiece Iol W/Ultrasert Delivery System | 150 | 0 | 0% |
| MONARCH IOL Delivery System, Cartridge | 220 | 26 | 0% |
| Microstaar Foam Tip Plunger | 251 | 0 | 0% |
| Alcon | 180 | 2 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about AcrySof IQ Singlepiece IOL with ULTRASERT Delivery System reports
How many FDA reports name AcrySof IQ Singlepiece IOL with ULTRASERT Delivery System?
1,878 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 244 in the latest 12 months.
What kinds of events are reported?
malfunction (84.9%) and injury (15.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device damaged by another device (11.4%), break (11.2%), failure to advance (10.3%), failure to eject (8.7%) and device difficult to setup or prepare (7.7%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that AcrySof IQ Singlepiece IOL with ULTRASERT Delivery System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.